Fasting Human Pancreatic Polypeptide (HPP) Level is not a Reliable Marker of Pancreatic Cancer, Chronic Pancreatitis or Type 3C (Pancreatogenic) Diabetes Mellitus (DM)

2017 ◽  
Vol 152 (5) ◽  
pp. S495
Author(s):  
Sajan Jiv Singh Nagpal ◽  
Amrit K. Kamboj ◽  
Raghuwansh P. Sah ◽  
William R. Bamlet ◽  
Suresh T. Chari
2016 ◽  
Vol 1 (3) ◽  
pp. 226-237 ◽  
Author(s):  
Phil A Hart ◽  
Melena D Bellin ◽  
Dana K Andersen ◽  
David Bradley ◽  
Zobeida Cruz-Monserrate ◽  
...  

2016 ◽  
Vol 10 (1) ◽  
pp. 36-39
Author(s):  
Md Hafizur Rahman ◽  
Md Yusuf Ali

Diabetes mellitus is a common disease among patients with pancreatic cancer and chronic pancreatitis. Hyperinsulinemia and peripheral insulin resistance are the prevailing diabetic traits in pancreatic cancer, whereas reduced islet cell mass and impaired insulin secretion are typically observed in chronic pancreatitis. Whether or not a causal relationship exists between diabetes and pancreatic carcinoma is an intriguing but unanswered question. Diabetes often precedes pancreatic cancer and is thus regarded as a potential risk factor for malignancy. Conversely, pancreatic cancer may secrete diabetogenic factors. Given these findings, there is increasing interest in whether close monitoring of the glycaemic profile may aid early detection of pancreatic tumor lesions. Exocrine pancreatic insufficiency is frequently associated with diabetes, with high prevalence in both insulin-dependent and insulinindependent patients. The incidence of diabetes caused by exocrine pancreatic disease appears to be underestimated and may comprise 8% or more of the general diabetic patient population. Non-endocrine pancreatic disease can cause diabetes by multiple mechanisms. Genetic defects have been characterized, resulting in a syndrome of both exocrine and endocrine failure. Regulation of beta cell mass and physiological incretin secretion are directly dependent on normal exocrine function. Algorithms for diagnosis and therapy of diabetes should therefore address both endocrine and exocrine pancreatic function.Faridpur Med. Coll. J. Jan 2015;10(1): 36-39


Author(s):  
Kaka Renaldi ◽  
Teddy Septianto ◽  
Dadang Makmun

Background: Pancreatic cancer is a very rare cancer with age-adjusted rates ranging from about 5 to 10 new cases per 100,000 persons per year. It has one of the worst prognoses of any type of cancer, with a 5-year survival rate of only 4.6%. Several risk factors have been identified, including older age, smoking, familial history of pancreatic cancer, obesity, chronic pancreatitis, diabetes mellitus, and alcohol consumption.Method: This was a descriptive study describing the risk factors of patients who were diagnosed with pancreatic cancer in the period between 1 January 2014 – 1 January 2019 at the Cipto Mangunkusumo National Referral Hospital (RSCM) Jakarta. Data were obtained from the medical records and Endoscopic Retrograde Cholangiopancreatography (ERCP) database from the RSCM Gastrointestinal Endoscopy Center.Results: From January 2014 to January 2019 there were 123 patients with newly diagnosed pancreatic cancer in RSCM. The mean age was 52 years old. The incidence of pancreatic cancer is more common in men (53%) than women (47%). The most common risk factor identified is smoking which was found in 29% of patients, followed by obesity at 27.9% and a history of diabetes mellitus at 19.5%. Risk factors with a fairly low prevalence include alcohol consumption at 9.7% and chronic pancreatitis at 2.4%. No family history of pancreatic cancer is identified in any subject.Conclusion: Smoking, obesity, and diabetes mellitus are common risk factors in pancreatic cancer patients. In contrast, chronic pancreatitis, alcohol consumption, and family history of pancreatic cancer are less commonly identified in patients.


1982 ◽  
Vol 17 (1) ◽  
pp. 25-30 ◽  
Author(s):  
Masahiro Matsumoto ◽  
Hideyuki Wakasugi ◽  
Hiroshi Ibayashi

2020 ◽  
Vol 95 (1) ◽  
pp. 50-55
Author(s):  
Seung-Ho Baek ◽  
Seung Soo Lee ◽  
Ji Hoon Kim ◽  
So Hyun Kim ◽  
Jihye Lim ◽  
...  

Pancreatic cancer is one of the most lethal malignancies worldwide. The risk of developing pancreatic cancer increases with age. Pancreatic cancer is seen mostly in the elderly; patients under the age of 30 years are rare. Known risk factors for pancreatic cancer include genetic mutations, smoking, chronic pancreatitis, and diabetes mellitus. We report a case of pancreatic cancer in a 27-year-old man without the PRSS1 mutation. Chronic pancreatitis and smoking may have contributed to the development of pancreatic cancer in this patient. We also conducted a literature review on early onset pancreatic cancer.


Pancreas ◽  
2018 ◽  
Vol 47 (10) ◽  
pp. 1239-1243 ◽  
Author(s):  
Phil A. Hart ◽  
Dana K. Andersen ◽  
Kieren J. Mather ◽  
Alicia C. Castonguay ◽  
Mandeep Bajaj ◽  
...  

2020 ◽  
Vol 16 (24) ◽  
pp. 84-90
Author(s):  
K.A. Nikolskaya ◽  
◽  
T.N. Kuzmina ◽  
Ye.A. Dubtsova ◽  
M.A. Kiryukova ◽  
...  

Presented the case of complex examination of a patient with pancreatic cancer using a bioimpedance method for assessing the nutritional status before and after surgical treatment. Provided the literature data related to this problem. The presented clinical case demonstrates the features of correction of the nutritional status of a patient with conditionally resectable pancreatic cancer in conditions of cholestasis, severe external pancreatic insufficiency and pancreatogenic diabetes mellitus on the background of constitutional obesity


Sign in / Sign up

Export Citation Format

Share Document